| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |